News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Raffaele Colombo highlights FDA Breakthrough Device Designation for Roche’s TROP2 diagnostic assay
Raffaele Colombo/LinkedIn
May 4, 2025, 03:18

Raffaele Colombo highlights FDA Breakthrough Device Designation for Roche’s TROP2 diagnostic assay

Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared a post on X by Stephen V Liu, adding:

“Based on AstraZeneca’s QCS for TROP2,
Roche Diagnostics received FDA Breakthrough Device Designation (BDD) for the VENTANA TROP2 (EPR20043) RxDx assay!
Nice spotlight presentation at AACR25.”

Read more about Roche’s FDA Breakthrough Device Designation for AI-driven NSCLC diagnostic here.

Raffaele Colombo

Quoting Stephen V Liu‘s post:

“Dr. Marina Garassino at WCLC24 Presidential Plenary presents Normalized Membrane Ratio of TROP2 as a biomarker for datopotamab deruxtecan in TROPION-Lung01 (Dato-DXd vs docetaxel in previously treated NSCLC which previously showed PFS benefit with Dato-DXd.“

Stephen V Liu

Learn more about Raffaele Colombo and TROPION-Lung01 on OncoDaily. 

AACR AACR25 AstraZeneca Breakthrough Device Designation cancer Dato-DXd datopotamab deruxtecan FDA Marina Garassino Medicine at Georgetown University NSCLC OncoDaily Oncology Roche Diagnostics Stephen V Liu TROP2 TROPION-Lung01 VENTANA TROP2 WCLC24 Zymeworks
Special Coverage
Blog
May 21, 2025, 04:12
Matthias Guckenberger: Spring meeting of the EORTC Lung Cancer Group
Blog
May 21, 2025, 03:33
Armenia’s Commitment to Cancer Care is very impressive - The Max Foundation
Blog
May 21, 2025, 01:40
Teresa Amaral: 5th edition of YO Congress
Blog
May 20, 2025, 17:22
The Lancet Group's Editorial Team Will Be on the Ground at ASCO 2025
Blog
May 20, 2025, 17:11
Pam Traxel: One in Ten Cancer Survivors Rely on Medicaid - Cuts Have Consequences
Blog
May 20, 2025, 16:58
Elvina Majiwa and Murallitharan Munisamy Have Won The World No Tobacco Day Award - UICC
Blog
May 20, 2025, 16:56
PER Tumor Board: Applying Recent Advances to Transform the Treatment Paradigm in SCLC
Blog
May 20, 2025, 16:46
Shahrin Ahmed: Specific Pre-surgery Medication Improves Survival Rates in Hereditary Breast Cancer Cases
Blog
May 20, 2025, 16:43
Ahmed Magdy Rabea: Pleased to Give a Multiple Myeloma Awareness Session to the Pfizer Egypt Team
Blog
May 20, 2025, 16:37
Sachin Jain: The Greatest Impact of AI Will Come from Improving Care and Service
Blog
May 20, 2025, 16:27
It Is Time to Invest in Cancer Research - Stand Up To Cancer
Insight
May 20, 2025, 15:50
Oliver Bogler Announced the Launch of the NanCI AI Webapp for Scientific Literature and Networking